The Global Impact of Fake Medicine

Substandard and counterfeit medicines are a global, growing, and increasingly deadly menace. Last year, the Food and Drug Administration reported the deaths of ninety-five Americans from tainted heparin, a blood-thinning medicine believed to have been "intentionally contaminated" in China; this spring, at least eighty-four Nigerian children died after ingesting teething medicine laced with diethylene glycol, a common component of antifreeze.

In addition to posing life-threatening dangers, substandard medicines increase drug resistance, threatening the viability of future treatment for diseases like HIV and malaria; counterfeit drugs also undermine incentives for R&D of new drugs. And while bilateral and international health initiatives spend billions of taxpayer dollars on pharmaceutical drugs for the developing world every year, oversight is minimal, and little direct quality testing is done on the drugs procured.

What are the best, most cost-effective ways for identifying counterfeit and substandard drugs in the field? How can consumers, regulatory bodies, industry, and international donor agencies work together to combat their deadly impact?

Please join experts from government, industry, and the international donor community for discussions on the extent of the problem, on what the public and private sectors are currently doing to combat it, and on how they can leverage innovative technological and policy solutions in the future. Panelists will include Ilisa Bernstein, director of pharmacy affairs at the FDA; Patrick Ford, senior director of global security for Pfizer; Jeffrey Gren, director of health and consumer goods at the U.S. Department of Commerce; Sonali Korde, a key player in the $1.2 billion President's Malaria Initiative; Scott LaGanga, executive director of the Partnership for Safe Medicines; Patrick Lukulay, director of drug quality and information at U.S. Pharmacopeia, the official NGO responsible for setting quality standards for all medicines manufactured in the United States; Paul Orhii, director general of Nigeria's National Agency for Food and Drug Administration and Control; and Richard Tren, founder and director of the health policy and advocacy group Africa Fighting Malaria. Moderating the two panels will be, respectively, AEI's Roger Bate and Michael Miller, who helped launch permanent FDA offices in China and India.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Roger
Bate

What's new on AEI

Expanding opportunity in America
image Moving beyond fear: Addressing the threat of the Islamic state in Iraq and Syria
image Foreign policy is not a 'CSI' episode
image The Air Force’s vital role
AEI on Facebook
Events Calendar
  • 21
    MON
  • 22
    TUE
  • 23
    WED
  • 24
    THU
  • 25
    FRI
Monday, July 21, 2014 | 9:15 a.m. – 11:30 a.m.
Closing the gaps in health outcomes: Alternative paths forward

Please join us for a broader exploration of targeted interventions that provide real promise for reducing health disparities, limiting or delaying the onset of chronic health conditions, and improving the performance of the US health care system.

Monday, July 21, 2014 | 4:00 p.m. – 5:30 p.m.
Comprehending comprehensive universities

Join us for a panel discussion that seeks to comprehend the comprehensives and to determine the role these schools play in the nation’s college completion agenda.

Tuesday, July 22, 2014 | 8:50 a.m. – 12:00 p.m.
Who governs the Internet? A conversation on securing the multistakeholder process

Please join AEI’s Center for Internet, Communications, and Technology Policy for a conference to address key steps we can take, as members of the global community, to maintain a free Internet.

Thursday, July 24, 2014 | 9:00 a.m. – 10:00 a.m.
Expanding opportunity in America: A conversation with House Budget Committee Chairman Paul Ryan

Please join us as House Budget Committee Chairman Paul Ryan (R-WI) unveils a new set of policy reforms aimed at reducing poverty and increasing upward mobility throughout America.

Thursday, July 24, 2014 | 6:00 p.m. – 7:15 p.m.
Is it time to end the Export-Import Bank?

We welcome you to join us at AEI as POLITICO’s Ben White moderates a lively debate between Tim Carney, one of the bank’s fiercest critics, and Tony Fratto, one of the agency’s staunchest defenders.

Event Registration is Closed
No events scheduled this day.
No events scheduled this day.
No events scheduled today.
No events scheduled this day.
No events scheduled this day.